Skinvisible, Inc.
SKVI
$0.58
$0.047.41%
| Weiss Ratings | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.46 | |||
| Price History | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 7.41% | |||
| 30-Day Total Return | 95.29% | |||
| 60-Day Total Return | 5.45% | |||
| 90-Day Total Return | -27.32% | |||
| Year to Date Total Return | 82.97% | |||
| 1-Year Total Return | 544.44% | |||
| 2-Year Total Return | 468.63% | |||
| 3-Year Total Return | 326.47% | |||
| 5-Year Total Return | 1,105.82% | |||
| 52-Week High % Change | -31.75% | |||
| 52-Week Low % Change | 850.82% | |||
| Price | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.85 | |||
| 52-Week Low Price | $0.06 | |||
| 52-Week Low Price (Date) | Mar 14, 2024 | |||
| 52-Week High Price (Date) | Aug 20, 2024 | |||
| Valuation | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.08M | |||
| Enterprise Value | 9.30M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.26 | |||
| Earnings Per Share Growth | -51.81% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 131.82 | |||
| Price/Book (Q) | -0.29 | |||
| Enterprise Value/Revenue (TTM) | 465.01 | |||
| Price | $0.58 | |||
| Enterprise Value/EBITDA (TTM) | -18.34 | |||
| Enterprise Value/EBIT | -17.63 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.54M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702 433 7154 | |||
| Address | 6320 South Sandhill Road Las Vegas, NV 89120 | |||
| Website | www.skinvisible.com | |||
| Country | United States | |||
| Year Founded | 1998 | |||
| Profitability | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2,637.00% | |||
| Profit Margin | -5,921.00% | |||
| Management Effectiveness | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -197.56% | |||
| Return on Equity | -- | |||
| Income Statement | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 20.00K | |||
| Total Revenue (TTM) | 20.00K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 20.00K | |||
| EBITDA (TTM) | -507.20K | |||
| EBIT (TTM) | -527.40K | |||
| Net Income (TTM) | -1.18M | |||
| Net Income Avl. to Common (TTM) | -1.18M | |||
| Total Revenue Growth (Q YOY) | 0.00% | |||
| Earnings Growth (Q YOY) | 0.31% | |||
| EPS Diluted (TTM) | -0.26 | |||
| EPS Diluted Growth (Q YOY) | 0.32% | |||
| Balance Sheet | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 600.00 | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 27.40K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -9.87M | |||
| Current Ratio (Q) | 0.006 | |||
| Book Value Per Share (Q) | -$2.02 | |||
| Total Assets (Q) | 148.60K | |||
| Total Current Liabilities (Q) | 4.64M | |||
| Total Debt (Q) | 6.22M | |||
| Total Liabilities (Q) | 10.02M | |||
| Total Common Equity (Q) | -9.87M | |||
| Cash Flow | SKVI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -9.20K | |||
| Cash from Financing (TTM) | 65.90K | |||
| Net Change in Cash (TTM) | -100.00 | |||
| Levered Free Cash Flow (TTM) | 370.80K | |||
| Cash from Operations (TTM) | -56.70K | |||
